FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021009046> ?p ?o ?g. }

• W2021009046 endingPage "1286" @default.
• W2021009046 startingPage "1275" @default.
• W2021009046 abstract "Clinical trials have documented the single-agent efficacy of radioimmunotherapy (RIT) in lymphoma, and several combination therapy studies are now in progress. RIT agents are currently becoming generally available for clinical use in lymphoma therapy. Solid tumors, which are notoriously less responsive to any single agent, have demonstrated clinically useful responses, albeit temporary, and multimodality studies have been instituted. However, a sincere debate continues regarding the basic parameters to be used to define appropriate therapeutic dosing when using this modality in clinical cancer care. It is a good time to reevaluate relevant dose response information from preclinical and clinical RIT. Preclinical studies have demonstrated abundant evidence of dose response in tumor and normal tissue in homogenous model systems; however, substantive variation occurs between the dose responses of tumors with low and variable (or shed) antigen expression, as well as between histologically different tumor models. Clinical studies of various heavily pretreated patient populations given several very different RIT pharmaceuticals have led to disparate conclusions regarding patient dosing methods and dosimetric predictions of toxicity and efficacy. Single-study data on previously untreated lymphoma patients with similar histology has demonstrated a correlation of imaging dosimetry with toxicity and tumor response. High-dose therapy with bone marrow support has also demonstrated a high tumor response rate and nonmarrow normal organ toxicities that correlate with the calculated dose to those organs from imaging. In iodine-131 ((131)I)--anti-CD20 studies, (131)I was demonstrated to have variable excretion, and estimated total-body radiation dose from tracer study proved a predictive surrogate for marrow toxicity. Yttrium-90 ((90)Y)--anti-CD20, which has little (90)Y excretion from the body, demonstrated the injected dose per body weight to be more predictive of marrow toxicity than indium-111 ((111)In) tracer dosimetry methods in heavily pretreated patients, and showed maximal safety with standard mCi/kg therapy dosing. Variations in clinical RIT choices, dosing methods, and dosimetry methods emphasize the need to review the relevant information to date. Future clinical trial designs, the sophistication of dosimetry, treatment planning, and clinical treatment decisions should all be focused on achieving the best benefit-risk relationship for each patient." @default.
• W2021009046 created "2016-06-24" @default.
• W2021009046 creator A5024722162 @default.
• W2021009046 creator A5038808449 @default.
• W2021009046 creator A5069302126 @default.
• W2021009046 creator A5080033344 @default.
• W2021009046 date "2002-02-12" @default.
• W2021009046 modified "2023-09-25" @default.
• W2021009046 title "Choosing an optimal radioimmunotherapy dose for clinical response" @default.
• W2021009046 cites W1573890015 @default.
• W2021009046 cites W1869307723 @default.
• W2021009046 cites W1931731730 @default.
• W2021009046 cites W1965649272 @default.
• W2021009046 cites W1966519301 @default.
• W2021009046 cites W1972784935 @default.
• W2021009046 cites W1973989299 @default.
• W2021009046 cites W1976197562 @default.
• W2021009046 cites W1979267242 @default.
• W2021009046 cites W1979714021 @default.
• W2021009046 cites W2004051439 @default.
• W2021009046 cites W2007252162 @default.
• W2021009046 cites W2015651479 @default.
• W2021009046 cites W2022127749 @default.
• W2021009046 cites W2025758025 @default.
• W2021009046 cites W2030513180 @default.
• W2021009046 cites W2035098455 @default.
• W2021009046 cites W2053127239 @default.
• W2021009046 cites W2054354760 @default.
• W2021009046 cites W2054823183 @default.
• W2021009046 cites W2073249238 @default.
• W2021009046 cites W2088602360 @default.
• W2021009046 cites W2093970895 @default.
• W2021009046 cites W2095258304 @default.
• W2021009046 cites W2111273332 @default.
• W2021009046 cites W2122716219 @default.
• W2021009046 cites W2135157531 @default.
• W2021009046 cites W2146338655 @default.
• W2021009046 cites W2162910425 @default.
• W2021009046 cites W2169133740 @default.
• W2021009046 cites W2320751441 @default.
• W2021009046 cites W29337223 @default.
• W2021009046 doi "https://doi.org/10.1002/cncr.10297" @default.
• W2021009046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11877757" @default.
• W2021009046 hasPublicationYear "2002" @default.
• W2021009046 type Work @default.
• W2021009046 sameAs 2021009046 @default.
• W2021009046 citedByCount "26" @default.
• W2021009046 countsByYear W20210090462012 @default.
• W2021009046 countsByYear W20210090462016 @default.
• W2021009046 countsByYear W20210090462022 @default.
• W2021009046 crossrefType "journal-article" @default.
• W2021009046 hasAuthorship W2021009046A5024722162 @default.
• W2021009046 hasAuthorship W2021009046A5038808449 @default.
• W2021009046 hasAuthorship W2021009046A5069302126 @default.
• W2021009046 hasAuthorship W2021009046A5080033344 @default.
• W2021009046 hasConcept C121608353 @default.
• W2021009046 hasConcept C126322002 @default.
• W2021009046 hasConcept C143998085 @default.
• W2021009046 hasConcept C159654299 @default.
• W2021009046 hasConcept C203014093 @default.
• W2021009046 hasConcept C2776146153 @default.
• W2021009046 hasConcept C2777288759 @default.
• W2021009046 hasConcept C2779338263 @default.
• W2021009046 hasConcept C2989005 @default.
• W2021009046 hasConcept C509974204 @default.
• W2021009046 hasConcept C535046627 @default.
• W2021009046 hasConcept C542903549 @default.
• W2021009046 hasConcept C71924100 @default.
• W2021009046 hasConceptScore W2021009046C121608353 @default.
• W2021009046 hasConceptScore W2021009046C126322002 @default.
• W2021009046 hasConceptScore W2021009046C143998085 @default.
• W2021009046 hasConceptScore W2021009046C159654299 @default.
• W2021009046 hasConceptScore W2021009046C203014093 @default.
• W2021009046 hasConceptScore W2021009046C2776146153 @default.
• W2021009046 hasConceptScore W2021009046C2777288759 @default.
• W2021009046 hasConceptScore W2021009046C2779338263 @default.
• W2021009046 hasConceptScore W2021009046C2989005 @default.
• W2021009046 hasConceptScore W2021009046C509974204 @default.
• W2021009046 hasConceptScore W2021009046C535046627 @default.
• W2021009046 hasConceptScore W2021009046C542903549 @default.
• W2021009046 hasConceptScore W2021009046C71924100 @default.
• W2021009046 hasIssue "S4" @default.
• W2021009046 hasLocation W20210090461 @default.
• W2021009046 hasLocation W20210090462 @default.
• W2021009046 hasOpenAccess W2021009046 @default.
• W2021009046 hasPrimaryLocation W20210090461 @default.
• W2021009046 hasRelatedWork W1986478975 @default.
• W2021009046 hasRelatedWork W1994649805 @default.
• W2021009046 hasRelatedWork W2036593974 @default.
• W2021009046 hasRelatedWork W2059348629 @default.
• W2021009046 hasRelatedWork W2384708512 @default.
• W2021009046 hasRelatedWork W2626305311 @default.
• W2021009046 hasRelatedWork W2947337648 @default.
• W2021009046 hasRelatedWork W3029154257 @default.
• W2021009046 hasRelatedWork W3031528520 @default.
• W2021009046 hasRelatedWork W93754128 @default.
• W2021009046 hasVolume "94" @default.
• W2021009046 isParatext "false" @default.

• next